Quantcast

Latest German inventions Stories

2011-05-18 10:37:00

REDWOOD CITY, Calif., May 18, 2011 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. announced today that the results from its Phase 2 clinical studies related to two product candidates, ARX-01 Sufentanil NanoTab(R) PCA System, which is designed to solve the problems associated with post-operative intravenous patient-controlled analgesia and ARX-03 to provide mild sedation, anxiety reduction and pain relief for patients undergoing painful procedures in a physician's office, will be featured in...

130a0207b5300f22ebec1cb90058441c
2011-05-02 08:55:00

Prescriptions for narcotics often contain too much medication per dose Parents who give young children prescription painkillers should take extra care to make sure they give just the right amount. What they may be surprised to learn, however, is that the dose given to them by the pharmacy could be too high, according to research to be presented Saturday, April 30, at the Pediatric Academic Societies (PAS) annual meeting in Denver. Researchers from South Carolina identified the top 19...

2011-04-22 07:23:00

TALLAHASSEE, Fla., April 22, 2011 /PRNewswire/ -- The Florida Society of Pain Management Providers (www.Flspmp.org) urges Government, Law Enforcement and the media to stop using false prescription drug data and statistics. The continued release of false and / or out of context information is solely intended to enflame the public. The misinformation that unfairly portrays Florida as ground zero in this issue has significant consequences for pain management patients and the physicians who...

2011-04-14 07:31:00

SYDNEY, Australia and BEDMINSTER, N.J., April 14, 2011 /PRNewswire/ -- QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today that the United States Patent and Trademark Office (USPTO) issued the Company a new patent, U.S. Patent #7,923,453, which expires in 2029. This patent covers a proprietary dosing algorithm for converting patients from intravenous opioid administration to orally administered MoxDuo IR, thereby more effectively and safely managing acute pain following surgery....

2011-04-05 22:09:48

JAMA studies identify shift in prescribing patterns and recommend interventions to protect vulnerable populations Two reports by addiction researchers at the University of Pennsylvania School of Medicine and the National Institute on Drug Abuse show a drastic shift in prescribing patterns impacting the magnitude of opioid substance abuse in America. The reports, published in JAMA, recommend a comprehensive effort to reduce public health risks while improving patient care, including better...

2011-04-04 06:00:00

SAN DIEGO, April 4, 2011 /PRNewswire/ -- Millennium Laboratories, a leading provider of therapeutic drug monitoring and education to physicians and staff treating chronic pain, and the Millennium Research Institute, a national non-profit research center, have become contributing sponsors of the Tufts Health Care Institute Program on Opioid Risk Management. Through a series of summit meetings and special projects, the THCI Program on Opioid Risk Management provides a neutral educational...

2011-03-30 07:00:00

SHELTON, Conn., March 30, 2011 /PRNewswire/ -- Cara Therapeutics, Inc. today announced the appointment of James B. Jones, M.D., Pharm.D., to the position of Chief Medical Officer. In this role, Dr. Jones will oversee the ongoing clinical development of Cara's lead drug candidate, CR845, a novel, peripherally-restricted kappa opioid agonist, which is currently in Phase 2 development for treatment of post-operative pain. "We are delighted to add someone of Jim's clinical background and drug...

2011-03-25 14:11:00

SAN CARLOS, Calif., March 25, 2011 /PRNewswire/ -- PharmacoFore, Inc., a privately held biopharmaceutical company developing next-generation abuse-resistant prescription drugs, announced that Lynn R. Webster, M.D., FACPM, FASAM, Co-Founder and Medical Director of Lifetree Clinical Research, will introduce the Company's novel technology during the 27th Annual American Academy of Pain Medicine (AAPM) Meeting. Dr. Webster's presentation, titled "New Opioid Formulations and Delivery Systems,"...

2011-03-24 20:17:18

An orphan drug originally used for HIV treatment has been found to short-circuit the process that results in additional sensitivity and pain from opioid use. The study by researchers at the Indiana University School of Medicine is reported in the March 25, 2011 issue of Brain, Behavior and Immunity. The researchers say the finding in animal models may ultimately make morphine a safer and more effective drug. Traditionally opioids were used to relieve pain following surgery, from cancer and at...

2011-03-24 07:24:00

LONDON and MAGNOLIA, Texas, March 24, 2011 /PRNewswire/ -- - First Potential New Active Cough Treatment in Over 50 Years SEEK, a leading UK privately-owned drug-discovery group and Pernix(TM) Therapeutics Holdings, Inc. (NYSE Amex: PTX), a specialty pharmaceutical company primarily focused on the pediatric market, today announced that they have engaged J.P.Morgan to auction the theobromine assets of the joint venture. The auction will be for the global commercialisation rights...


Word of the Day
cock-a-hoop
  • Exultant; jubilant; triumphant; on the high horse.
  • Tipsy; slightly intoxicated.
This word may come from the phrase 'to set cock on hoop,' or 'to drink festively.' Its origin otherwise is unclear. A theory, according to the Word Detective, is that it's a 'transliteration of the French phrase 'coq a huppe,' meaning a rooster displaying its crest ('huppe') in a pose of proud defiance.' Therefore, 'cock-a-hoop' would 'liken a drunken man to a boastful and aggressive rooster.'
Related